A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib

被引:0
|
作者
Ilhan, Osman [1 ]
Seval, Guldane Cengiz [1 ]
Bozdag, Sinem Civriz [1 ]
Deveci, Burak [2 ]
Pehlivan, Mustafa [3 ]
Kaynar, Leylagul [4 ]
Yavasoglu, Irfan [5 ]
Bekoz, Huseyin [6 ]
Hindilerden, Ipek Yonal [7 ]
Yegin, Zeynep Arzu [8 ]
Dagdas, Simten [9 ]
Avsar, Ayse [10 ]
Ozkan, Atilla Hasan [11 ]
Tuglular, Tulin Firat [12 ]
Goker, Hakan [10 ]
Golbas, Zafer [13 ]
机构
[1] Ankara Univ, Ankara, Turkey
[2] Antalya Medstar Hosp, Antalya, Turkey
[3] Gaziantep Univ, Gaziantep, Turkey
[4] Erciyes Univ, Kayseri, Turkey
[5] Adnan Menderes Univ, Aydin, Turkey
[6] Medipol Univ, Istanbul, Turkey
[7] Istanbul Univ, Istanbul, Turkey
[8] Gazi Univ, Ankara, Turkey
[9] Bilkent City Hosp, Ankara, Turkey
[10] Hacettepe Univ, Ankara, Turkey
[11] Yeditepe Univ, Istanbul, Turkey
[12] Marmara Univ, Istanbul, Turkey
[13] Anadolu Med Ctr Hosp, Kocaeli, Turkey
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P195
引用
收藏
页码:329 / 330
页数:2
相关论文
共 50 条
  • [1] Ruxolitinib plus etanercept for patients with steroid-refractory acute graft versus host disease after allogeneic stem cell transplantation
    Zhao, Yanmin
    Shi, Jinmin
    Luo, Yi
    Tan, Yamin
    Lan, Jianping
    Chen, Lieguang
    Huang, He
    BONE MARROW TRANSPLANTATION, 2019, 54 : 298 - 298
  • [2] Role of Ruxolitinib in Steroid-Refractory Graft versus Host Disease in Patients Undergoing Allogeneic Stem Cell Transplant
    Javed, Hammad
    Chaudhry, Qamarunnisa
    Shahbaz, Nighat
    Khan, Mehreen Ali
    Iftikhar, Raheel
    Yousaf, Muhammad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (09): : 1225 - 1227
  • [3] Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Wu, Hengwei
    Shi, Jimin
    Luo, Yi
    Tan, Yamin
    Zhang, Mingming
    Lai, Xiaoyu
    Yu, Jian
    Liu, Lizhen
    Fu, Huarui
    Huang, He
    Zhao, Yanmin
    JAMA NETWORK OPEN, 2021, 4 (01)
  • [4] Ruxolitinib treatment for steroid-refractory graft-versus-host disease
    Park, Han-Seung
    Lee, Je-Hwan
    Lee, Jung-Hee
    Choi, Eun-Ji
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Kyoo-Hyung
    BONE MARROW TRANSPLANTATION, 2019, 54 : 323 - 324
  • [5] Infliximab for the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in allogeneic stem cell transplant patients
    Rajpal, R
    Vandenberghe, E
    Browne, P
    Mccann, S
    King, F
    Conneally, E
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 113 - 113
  • [6] Combined Cytokine Blocking Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft Versus Host Disease (SR-GvHD)
    Pourhassan, Hoda
    Nguyen, Tina
    Yang, Dongyun
    Othman, Tamer
    Koller, Paul B.
    Blackmon, Amanda
    Agrawal, Vaibhav
    Ball, Brian J.
    Amanam, Idoroenyi
    Arslan, Shukaib
    Otoukesh, Salman
    Sandhu, Karamjeet S.
    Aldoss, Ibrahim
    Ali, Haris
    Salhotra, Amandeep
    Aribi, Ahmed
    Artz, Andrew
    Becker, Pamela S.
    Pullarkat, Vinod
    Stewart, Forest Marc
    Smith, Eileen Patricia
    Stein, Anthony
    Marcucci, Guido
    Forman, Stephen J.
    Nakamura, Ryotaro
    Al Malki, Monzr M.
    BLOOD, 2023, 142
  • [7] Alefacept for management of steroid-refractory graft-versus-host disease (GVHD) in patients undergoing allogeneic hematopoietic stem cell transplantation
    Toor, AA
    Stiff, PJ
    Nickeloff, BJ
    Gordon, KB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (01) : A2 - A2
  • [8] Ruxolutinib in Steroid Refractory Graft Versus Host Disease (SR-GVHD): Systemic Literature Review
    Saleh, Mostafa F. Mohammed
    Hashmi, Shahrukh K.
    BLOOD, 2019, 134
  • [9] Ruxolitinib and extracorporeal photopheresis (ECP) for steroid refractory acute Graft versus Host Disease after allogeneic stem cell transplantation
    Modemann, Franziska
    Ayuk, Francis
    Wolschke, Christine
    Christopeit, Maximilian
    von Pein, Ute
    Janson, Dietlinde
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2018, 53 : 447 - 448
  • [10] Use of Ruxolitinib in Pediatric Patients with Steroid-Refractory Graft-versus-host Disease (GVHD)
    Becilli, Marco
    Merli, Pietro
    Pagliara, Daria
    Galaverna, Federica
    Algeri, Mattia
    Gaspari, Stefania
    Boccieri, Emilia
    Carta, Roberto
    Ruggeri, Annalisa
    Locatelli, Franco
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 631 - 631